Genentech‘s experimental oral therapy fenebrutinib has become the first Bruton’s tyrosine kinase (BTK) inhibitor to show positive Phase 3 results in both relapsing forms of multiple sclerosis (MS) and primary progressive MS (PPMS), the company announced. In what Genentech called “unprecedented results,” two late-stage trials testing…
Read more
A new wearable brain-mapping tool could dramatically change how doctors monitor people with multiple sclerosis (MS), making it easier to track disease progression and guide personalized care. Researchers showed the system, OPM-MEG, reliably detects abnormalities in the brain’s electrical activity in MS patients. The portable technology is a major…
When the lights come up at the MS Focus on Fashion gala, the runway will be more than a showcase for beautiful designs. The Nov. 14 event in Fort Lauderdale, Florida, will be a celebration of confidence and connection for people living with multiple sclerosis (MS), according to…
Scientists at Case Western Reserve University (CWRU) in Ohio will use a new $2.5 million donation from the Thomas F. Peterson Jr. Charitable Trust to develop therapeutic strategies for multiple sclerosis (MS) and other neurological diseases. The commitment will support Paul Tesar, PhD, a CWRU professor and director of the…
I’ve been blessed with extraordinary caregivers and people who have made my journey with multiple sclerosis (MS) profoundly different. When I was diagnosed, my world collapsed. Everything I knew about myself, my body, and my future became uncertain. I had fatigue and strange sensations — my body…
Get regular updates to your inbox.
